J&J’s Change To 340B Discounts Is ‘Inconsistent’ With Statute, HRSA Says

Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is “inconsistent” with the 340B statute, according to HRSA.
The post J&J’s Change To 340B Discounts Is ‘Inconsistent’ With Statute, HRSA Says appeared first on Above the Law.Skip to content

© 2024 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.